ESOT The European Society
for Organ Transplantation

What can we help you find?

Leading the way in transplantation

Filter results for:

Don't need the search bar? Close it here

Category: All

New course on post-transplant rehabilitation on Transplant Live

Denise De Salvo

ETAHP (The European Transplant Allied Healthcare Professionals) is thrilled to announce a new online course on post-transplant rehabilitation. This course provides transplant professionals with the tools necessary to support patient recovery after transplantation through a team-based approach. The first three modules address the foundations of person-centred care, physical activity and exercise, and psychosocial well-being. The patient perspective is

Of Interest: a recommendation by the Committee of Ministers of the Council of Europe

Chiara Parisotto

In September 2023, the Committee of Ministers of the Council of Europe issued a recommendation to member States on establishing national harmonised organ transplant registries to facilitate international data sharing.  In particular, it recommends that the governments of member States promote the development and maintenance of national transplant registries with a view to facilitating harmonisation

INVITATION TO PARTICIPATE IN A SURVEY BY THE BANFF WORKING GROUP ON ANTIBODY MEDIATED INJURY

Chiara Parisotto

The Antibody-Mediated Injury Working Group of the Banff Foundation on Allograft Pathology invites you to participate in a survey on Multidisciplinary Transplant Meetings. The care of transplant recipients is complex, requiring a collaborative and multi-disciplinary effort. Despite evidence supporting the benefit of a multidisciplinary approach in transplantation, very little is known regarding the actual proportion

Latest issue of Transplant International

Chiara Parisotto

In the latest issue of Transplant International, Zhang et al. show how they developed P-cube, a multi-step precision prediction pathway model using data from a national Australian kidney transplant cohort. This model was then validated using registry data from the United States and can be used to identify allograft survival-specific risk factors within a heterogeneous